|
|
|
Insider
Information: |
Cohen Raymond W |
Relationship: |
|
City: |
Irvine |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
284,273 |
|
Indirect Shares
|
692,151 |
|
|
Direct
Value |
$13,260,851 |
|
|
Indirect Value
|
$46,567,919 |
|
|
Total
Shares |
976,424 |
|
|
Total
Value |
$59,828,770 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
8
|
Stock
price went up :
|
0
|
4
|
Stock
price went down : |
0
|
4
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
88.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cardiac Science Corp |
CSCX |
Director |
2009-05-22 |
13,825 |
|
0 |
Premium* |
|
Spectrum Pharmaceuticals Inc |
SPPI |
Director |
2019-06-20 |
53,850 |
2013-12-13 |
0 |
Premium* |
|
Biolife Solutions Inc |
BLFS |
Director |
2021-07-12 |
27,763 |
2014-05-20 |
0 |
Premium* |
|
Axonics Modulation Technologies,... |
AXNX |
|
2024-01-31 |
188,835 |
2019-08-06 |
692,151 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2024-01-31 |
4 |
S |
$67.74 |
$2,381,662 |
D/D |
(35,161) |
188,835 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2024-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
63,400 |
223,996 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2023-02-01 |
4 |
S |
$60.43 |
$494,578 |
D/D |
(8,117) |
160,596 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,750 |
129,649 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2023-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
61,968 |
191,617 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2023-01-31 |
4 |
S |
$61.12 |
$1,400,595 |
D/D |
(22,904) |
168,713 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2023-01-13 |
4 |
S |
$65.54 |
$2,686,001 |
D/D |
(40,736) |
108,899 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2022-08-08 |
4 |
AS |
$69.50 |
$3,099,326 |
D/D |
(44,000) |
149,635 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2022-03-29 |
4 |
AS |
$60.00 |
$3,000,000 |
D/D |
(50,000) |
193,635 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2022-03-14 |
4 |
AS |
$50.42 |
$2,641,148 |
D/D |
(50,000) |
243,635 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2022-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
96,846 |
374,750 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2022-02-03 |
4 |
S |
$48.21 |
$1,694,371 |
D/D |
(35,115) |
339,635 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
43,297 |
277,904 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2021-09-09 |
4 |
AS |
$77.11 |
$3,855,350 |
D/D |
(50,000) |
234,607 |
0 |
% |
|
BLFS |
Biolife Solutions Inc |
Director |
|
2021-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
27,763 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2021-06-08 |
4 |
AS |
$60.00 |
$1,999,980 |
D/D |
(33,333) |
284,607 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2021-05-18 |
4 |
AS |
$55.00 |
$1,805,815 |
D/D |
(32,833) |
317,940 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2021-05-10 |
4 |
AS |
$52.98 |
$1,818,158 |
D/D |
(33,833) |
350,773 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2021-02-01 |
4 |
S |
$51.36 |
$700,661 |
D/D |
(13,627) |
456,096 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2021-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,334 |
469,723 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2021-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
436,389 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2021-01-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,173 |
424,231 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2021-01-26 |
4 |
S |
$53.58 |
$420,148 |
D/D |
(7,842) |
416,389 |
0 |
% |
|
BLFS |
Biolife Solutions Inc |
Director |
|
2020-11-12 |
4 |
S |
$32.45 |
$182,531 |
D/D |
(5,625) |
22,763 |
0 |
% |
|
BLFS |
Biolife Solutions Inc |
Director |
|
2020-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
28,388 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|